What are the chemotherapy options for lung cancer? 6 drug therapies are more reliable

More and more people are unfortunately suffering from malignant tumors such as lung cancer. After discovering that they have lung cancer, they must undergo chemotherapy. The conditions of different patients are different, so the time of chemotherapy is also different. The normal cycle is once every three to four weeks, during which white blood cells and transaminases need to be checked. What I will explain to you today is what chemotherapy options are there for lung cancer?

Lung cancer chemotherapy regimens:

1. Vinorelbine + cisplatin (NC) regimen

This is an earlier chemotherapy regimen for lung cancer. Medical experts have found through clinical statistics that the efficacy of this chemotherapy regimen for lung cancer patients is 26%, and the survival period of patients is as long as 8 months. And 36% of patients survive for one year. The efficacy is definitely better than using cisplatin alone.

2. Gemcitabine + cisplatin (GC) regimen

In recent years, the chemotherapy regimen for lung cancer that has been frequently used in clinical practice is gemcitabine + cisplatin (GC). Its efficacy is as high as 40.6%, and the median disease progression time is 6.9 months. The average survival time of patients is 8.7 months, which is slightly longer than the first chemotherapy regimen.

3. Paclitaxel plus cisplatin (PC) regimen

This regimen is the first choice for patients with advanced lung cancer. It has comparable short-term efficacy to other third-generation platinum-containing regimens, but has a shorter progression-free survival (PFS).

4. Erlotinib

If patients with advanced lung cancer are told by their doctors that they cannot receive chemotherapy, they can be given erlotinib, which can also appropriately prolong the patient's survival.

5. Afatinib

If the lung cancer patient has EGFR mutation, it is recommended that you use afatinib, a targeted drug, which can double the patient's survival time.

6. Bevacizumab-containing regimen

This chemotherapy regimen has an acceptable safety profile for patients with CNS metastases, and the response rates for patients with primary tumors, brain metastases, and other metastatic sites are similar, with a low incidence of intracranial hemorrhage.

The above article has recommended several chemotherapy regimens for lung cancer. It can be seen that there are many chemotherapy regimens for lung cancer patients. The specific one to be used depends on your doctor's condition. What the patient needs to do is to actively cooperate with the doctor for treatment. The clinical treatment effect of lung cancer is still good.